Trial intelligence / Profile preview

Indapamide PK and UGT2B7 Polymorphisms in Egyptians

NCT05294484Phase 4Unknown

Sponsor
Ain Shams University
Start
Mar 2022
Primary completion
Jul 2022
Modality
Small Molecules
01

Overview

A Phase 4 trial of indapamide in hypertension (HTN), sponsored by Ain Shams University. Status: unknown.

02

Drugs

indapamide
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT05294484.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05294484.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call